RCUS — Arcus Biosciences, Inc. catalysts
Next verified catalyst
2027-01-01 — A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adu · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01 (month) in 3mo
ESTIMATED |
READOUT
A Safety and Efficacy Study of Treatment Combinations With and Without Chemother
Phase 2 · Gastrointestinal Tract Malignancies |
RCUS Arcus Biosciences, Inc. | Domvanalimab, Quemliclustat, Zimberelima |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|